Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management

Drugs and Aging

Volumn 10, Issue 4, 1997, Pages 249-258

  Jost, Wolfgang H ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; DOMPERIDONE; ISPAGULA; LEVODOPA; METOCLOPRAMIDE;

ANAMNESIS; ANUS SPHINCTER DISORDER; BRAIN DEGENERATION; CLINICAL EXAMINATION; CONSERVATIVE TREATMENT; CONSTIPATION; DYSPHAGIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; HYPERSALIVATION; MYENTERIC PLEXUS; NERVE DEGENERATION; PARKINSON DISEASE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING;

EID: 0031001025     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710040-00002     Document Type: Review

References (77)

1. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones, 1817
2. Caplan LH, Jacobson HG, Rubinstein BM, et al. Megacolon and volvulus in Parkinson's disease. Radiology 1965; 85: 73-8
3. Eadie MJ, Tyrer JH. Alimentary disorders in parkinsonism. Australas Ann Med 1965; 14: 13-22
4. Edwards L, Quigley EMM, Hofman R, et al. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 1993; 8: 83-6
5. Edwards LL, Quigley EMM, Harned RK, et al. Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 1994; 89: 15-25
6. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990; 53: 463-8
7. Den Hartog Jager WA. Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. Arch Neurol 1969; 21: 615-9
8. Forno LS. The Lewy body in Parkinson's disease. Adv Neurol 1986; 45: 35-43
9. Kupsky WJ, Grimes MM, Sweeting J, et al. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987; 37: 1253-5
10. Ohama E, Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol (Berl) 1976; 34: 311-9
11. Qualman SJ, Haupt HM, Yang P, et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson's disease. Gastroenterology 1984; 87: 848-56
12. Wakabayashi K, Takahashi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol 1993; 60: 609-12
13. Edwards LL, Pfeiffer RF, Quigley EMM, et al. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 1991; 6: 151-6
14. Klaue R. Parkinsonsche Krankheit (Paralysis agitans) und post-encephalitischer Parkinsonismus. Archiv fur Psychiatrie 1940; 111: 251-321
15. Kuroiwa Y, Shimada Y, Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 1983; 33: 463-7
16. Oppenheim H. Kleine Beiträge zur Neuropathologie. J Psychol Neurol 1902; 1: 129-46
17. Koller WC. Handbook of Parkinson's disease. New York: Marcel Dekker Inc., 1992
18. Bateson MC, Gibberd FB, Wilson RSE. Salivary symptoms in Parkinson disease. Arch Neurol 1973; 29: 274-5
19. Schwab RS, England AC. Parkinson's disease. J Chronic Dis 1958; 8: 488-509
20. Palmai G, Blackwell B. The diurnal pattern of salivary flow in normal and depressed patients. Br J Psychiatry 1965; 111: 334-8
21. Parkes JD. Domperidone and Parkinson's disease. Clin Neuropharmacol 1986; 9: 517-32
22. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989; 39: 1309-14
23. Logemann JA, Blonsky ER, Boshes B. Dysphagia in parkinsonism. JAMA 1975; 231: 69-70
24. Nowack WJ, Hatelid JM, Sohn RS. Dysphagia in parkinsonism [letter]. Arch Neurol 1977; 34: 320
25. Fischer RA, Ellison GW, Thayer WR, et al. Esophageal motility in neuromuscular disorders. Ann Intern Med 1965; 63: 229-48
26. Calne DB, Shaw DG, Spiers ASD, et al. Swallowing in parkinsonism. Br J Radiol 1970; 43: 456-7
27. Eadie MJ, Tyrer JH. Radiological abnormalities of the upper part of the alimentary tract in parkinsonism. Australas Ann Med 1965; 14: 23-7
28. Palmer ED. Dysphagia in parkinsonism [editorial]. JAMA 1974; 229: 1349
29. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism - chronic treatment with L-dopa. N Engl J Med 1969; 280: 337-45
30. Bramble MG, Cunliffe J, Dellipiani AW. Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease. J Neurol Neurosurg Psychiatry 1978; 41: 709-12
31. Kempster PA, Lees AJ, Crichton P, et al. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine. Mov Disord 1989; 4: 47-52
32. Lieberman AN, Horowitz L, Redmond P, et al. Dysphagia in Parkinson's disease. Am J Gastroenterol 1980; 74: 157-60
33. Gibberd FB, Gleeson JA, Gossage AAR, et al. Oesophageal dilatation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1974; 37: 938-40
34. Jost WH, Schimrigk K. Cisapride treatment of constipation in Parkinson's disease. Mov Disord 1993; 8: 339-43
35. Kaneoke Y, Koike Y, Sakurai N, et al. Gastrointestinal dysfunction in Parkinson's disease detected by electrogastroenterography. J Auton Nerv Syst 1995; 50: 275-81
36. Djaldetti R, Baron J, Ziv I, et al. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996; 46: 1051-4
37. Kurlan R, Rubin AJ, Miller C, et al. Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism [abstract]. Ann Neurol 1985; 18: 139
38. Champion MC. Domperidone. Gen Pharmacol 1988; 19: 499-505
39. Mearrick PT, Wade DN, Birkett DJ, et al. Metoclopramide, gastric emptying and L-dopa absorption. Aust N Z J Med 1974; 4: 144-8
40. Wade DN, Mearrick PT, Birkett DT, et al. Variability of L-dopa absorption in man. Aust N Z J Med 1974; 4: 138-43
41. Rivera-Calimlim L, Dujovne CA, Morgan JP, et al. L-dopa treatment failure: explanation and correction. BMJ 1970; 4: 93-4
42. Indo T, Ando K. Metoclopramide-induced parkinsonism. Arch Neurol 1982; 39: 494-6
43. Paulseth JE, Jensen JJJ, Klawans HL. Domperidone therapy in patients with Parkinson's disease with levodopa-carbidopa-related gastrointestinal complaints. Ann Neurol 1984; 16: 127-8
44. Eadie MJ. Gastric secretion in parkinsonism. Australas Ann Med 1963; 12: 346-50
45. Bingham JR, Ingelfinger FJ, Smithwick RH. The effects of sympathectomy on the motility of the human gastrointestinal and biliary tracts. Gastroenterology 1950; 15: 6-17
46. Lewitan A, Nathanson L, Slade WR. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology 1951; 17: 367-74
47. Calne DB, Brennan J, Spiers ASD, et al. Hypotension caused by L-dopa. BMJ 1970; 1: 474-5
48. Jost WH, Schimrigk K. Constipation in Parkinson's disease. Klin Wochenschr 1991; 69: 906-9
49. Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses. Clin Auton Res 1993; 3: 339-44
50. Turkka JT, Juujärvi KK, Lapinlampi TO, et al. Serum noradrenaline response to standing up in patients with Parkinson's disease. Eur Neurol 1986; 25: 355-61
51. Wang SJ, Fuh JL, Shan DE, et al. Sympathetic skin response and R-R interval variation in Parkinson's disease. Mov Disord 1993; 8: 151-7
52. Pallis CA. Parkinsonism: natural history and clinical features. BMJ 1971; .3: 683-90
53. Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 1992; 32: 134-40
54. Kuroiwa Y, Wada T, Tohgi H. Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 1987; 235: 65-8
55. Porter RW, Bors E. Neurogenic bladder in parkinsonism: effect of thalamotomy. J Neurosurg 1971; 34: 27-32
56. Jost WH, Schimrigk K. Bestimmung der Kolontransitzeit beim Parkinson - Syndrom. Aktuelle Neurol 1992; 19: 52-3
57. Neundörfer B. Risiken und Nebenwirkungen der medikamentösen Therapie. Nervenheilkunde 1992; 11: 63-7
58. Siegmund H. Anatomisch nachgewiesene Folgen von Tonus-und Motilitätsstörungen des Verdauungskanals bei Enzephalitikern, die mit Atropin behandelt wurden. MMW Munch Med Wochenschr 1935; 82: 453-4
59. Jost WH, Jung G, Schimrigk K. Colonic transit in non-idiopathic Parkinson's syndrome. Eur Neurol 1994; 34: 329-31
60. Herm F, Jordan E, Jost WH, et al. Colontransitzeit bei neuromuskulären Erkrankungen vor und nach Colonreflexmassagen [abstract]. Med Klin 1995; 90: 199
61. Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960; 23: 283-90
62. Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain 1963; 86: 781-92
63. Oyanagi K, Wakabayashi K, Ohama E, et al. Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease. Acta Neuropathol 1990; 80: 558-9
64. Singaram C, Ashraf W, Quigley EMM, et al. Enteric nervous system (ENS) dopamine depletion in Parkinson's disease (PD) [abstract]. Mov Disord 1494; 9 Suppl. 1: 100
65. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988; 76: 217-21
66. Mathers SE, Kempster PA, Law PJ, et al. Anal sphincter dysfunction in Parkinson's disease. Arch Neurol 1989; 46: 1061-4
67. Ashraf W, Pfeiffer RF, Quigley EMM. Anorectal manometry in the assessment of anorectal function in Parkinson's disease: a comparison with chronic idiopathic constipation. Mov Disord 1994; 9: 655-63
68. Jost WH, Raulf F, Schimrigk K. Anismus: Definition, Pathophysiologie, Diagnose und Therapie. Kontinenz 1994; 3: 211-5
69. Mathers SE, Kempster PA, Swash M, et al. Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 1988; 51: 1503-7
70. Reboa G, Arnulfo G, Frascio M, et al. Colon motility and coloanal reflexes in chronic idiopathic constipation. Eur J Clin Pharmacol 1984; 26: 745-8
71. Djaldelti R, Koren M, Achiron A, et al. Effect of cisapride on response fluctuations in Parkinson's disease. Mov Disord 1995; 10: 81-4
72. Neira WD, Sanchez V, Mena MA, et al. The effects of cisapride on plasma L-dopa levels and response in Parkinson's disease. Mov Disord 1995; 10: 66-70
73. Jost WH, Schimrigk K. Long-term results with cisapride in Parkinson's disease. Mov Disord. In press
74. Jost WH, Schimrigk K. Elektromyogramm des M. sphincter uni externus beim idiopathischen Parkinson Syndrom. Aktuelle Neurol 1996; 23: 167-70
75. Wenning GK, Quinn N. Multisytematrophic. Aktuelle Neurol 1994; 21: 120-6
76. Jost WH. Neurologie des Beckenhodens. London: Chapman & Hall, 1997
77. Lewy FH. Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 1913; 50: 50-5